Suchergebnisse - (Subject:"Severe Acute Respiratory Syndrome")

PubPharm (9.475)

41

Appearance and Prevalence of JN.1 SARS-CoV-2 Variant in India and Its Clinical Profile in the State of Maharashtra

enthalten in: Cureus | 2024

von Karyakarte, R. | Das, R. | Rajmane, M. | +12

42

Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection

enthalten in: Emerging infectious diseases | 2024

von Vu, Q. | Fitzpatrick, A. | Cope, J. | +5

43

Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer : A case report

enthalten in: Oncology letters | 2024

von Zhang, X. | Chen, J. | Sun, J. | +3

44

Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Yang, W. | Wang, Y. | Han, D. | +2

45

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children : A MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF VARIANT-ADAPTED BNT162b2 RNA-BASED VACCINE CANDIDATE(S) IN HEALTHY CHILDREN

enthalten in: ClinicalTrials.gov | 2024

46

Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults : A comparative analysis with mRNA vaccines

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2024

von Sheng, W. | Lin, P. | Cheng, Y. | +5

47

Developing CAR-immune cell therapy against SARS-CoV-2 : Current status, challenges and prospects

enthalten in: Biochemical pharmacology | 2024

von Chen, Y. | Liu, C. | Fang, Y. | +5

48

Optimal timing of SARS-CoV-2 vaccination prior to cardiovascular surgery under cardiopulmonary bypass

enthalten in: The International journal of artificial organs | 2024

von Hayashi, R. | Takami, Y. | Fujigaki, H. | +6

49

Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure : Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure

enthalten in: ClinicalTrials.gov | 2024

50

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 : Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

enthalten in: ClinicalTrials.gov | 2024